The use of vasopressin for treating vasodilatory shock and cardiopulmonary arrest: State-of-the-Art-Review

Journal of Veterinary Emergency and Critical Care

Volumn 19, Issue 2, 2009, Pages 145-157

  Scroggin, Richard D ^a,b   Quandt, Jane ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Animal Cancer Center   (United States)

^c Animal Cancer Center ^*

Author keywords

Arginine vasopressin; Cardiopulmonary cerebral resuscitation; Sepsis; Septic shock

Indexed keywords

VASOCONSTRICTOR AGENT; VASOPRESSIN DERIVATIVE;

ANIMAL; ANIMAL DISEASE; DOMESTIC ANIMAL; HEART ARREST; HUMAN; REVIEW; SHOCK;

ANIMALS; ANIMALS, DOMESTIC; HEART ARREST; HUMANS; SHOCK; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

ANIMALIA;

EID: 65349083147     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1111/j.1476-4431.2008.00352.x     Document Type: Review

References (92)

1. Asfar P, Balazs H, Radermacher P, et al. Catecholamines and vasopressin during critical illness. Crit Care Clin 2006 22 : 131 149. (Pubitemid 43037114)
2. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med 2001 345 (8) : 558 595.
3. Holmes CL, Landry DW, Granton JT. Science review: vasopressin and the cardiovascular system part 2-clinical physiology. Crit Care 2004 8 : 15 23. (Pubitemid 38202135)
4. Scharte M, Meyer J, van Aken H, et al. Hemodynamic effects of terlipressin (a synthetic analog of vasopressin) in healthy and endotoxemic sheep. Crit Care Med 2001 29 (9) : 1756 1759. (Pubitemid 32848377)
5. Takakura K, Xianhong W, Takeuchi K, et al. Deactivation of norepinephrine by peroxynitrite as a new pathogenesis in the hypotension of septic shock. Anesthesiology 2003 98 (4) : 928 934. (Pubitemid 36373228)
6. Archer SL, Huang JMC, Hampl V, et al. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 1994 91 : 7583 7587.
7. Morales D, Madigan J, Cullinane S, et al. Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock. Circulation 1999 100 : 226 229. (Pubitemid 29340126)
8. Feldman EC, Nelson RW. Water metabolism and diabetes insipidus, In : Feldman EC, Nelson RW, eds. Canine and Feline Endocrinology and Reproduction, 3rd ed. Philadelphia : WB Saunders Co 2004, pp. 2 43.
9. Bourque CW, Oliet SHR, Richard D. Osmoreceptors, osmoreception, and osmoregulation. Front Neuroendocrinol 1994 15 : 231 274. (Pubitemid 24361627)
10. Swabb DF, Nijveldt F, Pool CW. Distribution of oxytocin and vasopressin in the rat suproptic and paraventricular nucleus. J Endocr 1975 67 : 461 462.
11. Rose DB, Post TW. Effects of hormones on renal function, In : Rose DB, Post TW, eds. Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed. New York : McGraw-Hill Co 2001, pp. 163 238.
12. Leng G, Brown CH, Russel JA. Physiological pathways regulating the activity of magnocellular neurosecretory cells. Prog Neurobiol 1999 57 : 625 655. (Pubitemid 29148418)
13. Holmes CL, Patel BM, Russell JA, et al. Physiology of vasopressin relevant to management of septic shock. Chest 2001 120 : 989 1002. (Pubitemid 32885477)
14. Czaczkes JW. Physiologic studies of antidiuretic hormone by its direct measurement in human plasma. J Clin Invest 1964 43 : 1625 1640.
15. Kovacs L, Robertson GL. Syndrome of inappropriate antidiuresis. Endocrinol Metab Clin North Am 1992 859 875. (Pubitemid 23005088)
16. Schrier RW, Berl T, Anderson RJ. Osmotic and nonosmotic control of vasopressin release. Am J Physiol 1979 236 (4) : F321 F332.
17. Guyton AC, Hall JE. Regulation of extracellular fluid osmolarity and sodium concentration, In : Guyton AC, Hall JE, eds. Textbook of Medical Physiology, 10th ed. Philadelphia : WB Saunders Co 2000, pp. 313 328.
18. Landry DW, Levin HR, Gallant EM, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997 95 (5) : 1122 1125. (Pubitemid 27097820)
19. Leng G, Dyball RE, Russell JA. Neurophysiology of body fluid homeostasis. Comp Biochem Physiol A 1988 90 : 781 788. (Pubitemid 18201972)
20. Wood CE, Chen HG. Acidemia stimulates ACTH, vasopressin, and heart rate responses in fetal sheep. Am J Physiol 1989 257 : R344 R349. (Pubitemid 19216969)
21. Sklar AH, Schrier RW. Central nervous system mediators of vasopressin release. Physiol Rev 1983 63 : 1243 1280.
22. Ried IA. Role of nitric oxide in the regulation of rennin and vasopressin secretion. Front Neuroendocrinol 1994 15 : 351 383.
23. Breitschwerdt EB, Root CR. Inappropriate secretion of antidiuretic hormone in a dog. J Am Vet Med Assoc 1979 175 (2) : 181 186.
24. Angstwurm M. Vasopressin: A tool as rescue therapy? Take care of dosages and adverse effects. Crit Care Med 2005 33 (11) : 2713 2714. (Pubitemid 41682146)
25. Holmes CL, Landry DW, Granton JT. Science review: vasopressin and the cardiovascular system part 1-receptor physiology. Crit Care 2003 7 : 427 434. (Pubitemid 37527228)
26. Bracco D, Dubois MJ. Hemodynamic support in septic shock: is restoring a normal blood pressure the right target? Crit Care Med 2005 33 (9) : 2113 2115. (Pubitemid 41306538)
27. Barberis C, Mouillac B, Durroux T. Structural bases of vasopressin/oxytocin receptor function. J Endocrinol 1998 156 : 223 229. (Pubitemid 28105809)
28. Szumita PM, Enfanto CM, Greenwood B, et al. Vasopressin for vasopressor-dependent septic shock. Am J Health-Syst Pharm 2005 62 : 1931 1936. (Pubitemid 41324178)
29. Asfar P, Pierrot M, Veal N, et al. Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats. Crit Care Med 2003 31 (1) : 215 220. (Pubitemid 36151174)
30. Asfar P, Hauser B, Ivanyi Z, et al. Low-dose terlipressin during long-term hyperdynamic porcine endotoxemia: effects on hepatosplanchnic perfusion, oxygen exchange, and metabolism. Crit Care Med 2005 33 (2) : 373 380. (Pubitemid 40216552)
31. Malay MB, Ashton JL, Dahl K, et al. Heterogeneity of the vasoconstrictory effect of vasopressin in septic shock. Crit Care Med 2004 32 (6) : 1327 1331. (Pubitemid 38738588)
32. Martikainen TJ, Tenhunen JJ, Uusaro A, et al. The effects of vasopressin on systemic and splanchnic hemodynamics and metabolism in endotoxin shock. Anesth Analg 2003 97 : 1756 1763. (Pubitemid 37475134)
33. Knotzer H, Maier S, Dunser MW, et al. Arginine vasopressin does not alter mucosal tissue oxygen tension and oxygen supply in an acute endotoxemic pig model. Intensive Care Med 2006 32 : 170 174. (Pubitemid 43039394)
34. Westphal M, Stubbe H, Sielenkamper AW, et al. Terlipressin dose response in healthy and endotoxemic sheep: impact on cardiopulmonary performance and global oxygen transport. Intensive Care Med 2003 29 : 301 308. (Pubitemid 36384421)
35. Westphal M, Stubbe H, Sielenkamper AW, et al. Effects of titrated arginine vasopressin on hemodynamic variables and oxygen transport in healthy and endotoxemic sheep. Crit Care Med 2003 31 (5) : 1502 1508. (Pubitemid 36583866)
36. Sun Q, Dimopoulos G, Nguyen DN, et al. Low-dose vasopressin in the treatment of septic shock in sheep. Am J Respir Crit Care Med 2003 168 (4) : 481 486. (Pubitemid 37046879)
37. Yoo JH, Kim MS, Park HM. Hemodynamic characteristics of vasopressin in dogs with severe hemorrhagic shock. J Vet Med Sci 2006 68 (9) : 967 972. (Pubitemid 44526558)
38. Silverstein DC, Waddell LS, Drobatz KJ, et al. Vasopressin therapy in dogs with dopamine-resistant hypotension and vasodilatory shock. J Vet Emerg Crit Care 2007 17 (4) : 399 408. (Pubitemid 350175968)
39. Malay MB, Ashton RC, Landry DW, et al. Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 1999 47 (4) : 699 703. (Pubitemid 29489521)
40. Klinzing S, Simon M, Reinhart K, et al. High-dose vasopressin in not superior to norepinephrine in septic shock. Crit Care Med 2003 31 (11) : 2646 2650. (Pubitemid 37455414)
41. O'Brien A, Clapp L, Singer M. Terlipressin for norepinephrine-resistant septic shock. Lancet 2002 359 : 1209 1210. (Pubitemid 34304264)
42. van Haren FMP, Rozendaal FW, van der Hoeven JG. The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock. Chest 2003 124 (6) : 2256 2260. (Pubitemid 38010597)
43. Morelli A, Rocco M, Conti G, et al. Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinectic septic shock. Intensive Care Med 2004 30 : 597 604. (Pubitemid 38530094)
44. Holmes CL, Walley KR, Chittock DR, et al. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med 2001 27 : 1416 1421. (Pubitemid 32758942)
45. Landry DW, Levin HR, Gallant EM, et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 1997 25 (8) : 1279 1282. (Pubitemid 27347289)
46. Tsuneyoshi I, Yamada H, Kakihana Y, et al. Hemodynamic and metabolic effects of low-dose vasopressin infusion in vasodilatory septic shock. Crit Care Med 2001 29 (3) : 487 493. (Pubitemid 32225288)
47. Patel BM, Chittock DR, Russell JA, et al. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002 96 : 576 582. (Pubitemid 34193495)
48. Dunser MW, Mayr AJ, Ulmer H, et al. Arginine vasopressin in advanced vasodilatory shock. Circulation 2003 107 : 2313 2319.
49. Leone M, Albanese J, Delmas A, et al. Terlipressin in catecholamine-resistant septic shock patients. Shock 2004 22 (4) : 314 319. (Pubitemid 39468969)
50. Dunser MW, Fries DR, Schobersberger W, et al. Does arginine vasopressin influence the coagulation system in advanced vasodilatory shock with severe multiorgan dysfunction syndrome? Anesth Analg 2004 99 : 201 206. (Pubitemid 38808191)
51. Luckner G, Dunser MW, Jochberger S, et al. Arginine vasopressin in 316 patients with advanced vasodilatory shock. Crit Care Med 2005 33 (11) : 2659 2666. (Pubitemid 41682122)
52. Dunser MW, Fries DR, Schobersberger W, et al. Does arginine vasopressin influence the coagulation system in advanced vasodilatory shock with severe multiorgan dysfunction syndrome? Anesth Analg 2004 99 : 201 216. (Pubitemid 38808191)
53. Felip J, Rosenkranz B. Mechanisms of vasopressin-induced platelet aggregation. Thromb Res 1987 45 : 7 15.
54. Schmid PG, Abbound FM, Wendling MG, et al. Regional vascular effects of vasopressin: plasma levels and circulatory responses. Am J Physiol 1974 227 (5) : 998 1004.
55. Garcia-Villalon AL, Garcia JL, Fernandez N, et al. Regional differences in the arterial response to vasopressin: role of endothelial nitric oxide. Br J Pharmacol 1996 260 (2-3) : 265 268. (Pubitemid 26252683)
56. Laszlo F, Karacsony G, Pavo I, et al. Aggressive role of vasopressin in development of different gastric lesion in rats. Eur J Pharmacol 1994 258 : 15 22. (Pubitemid 24174982)
57. Laszlo F, Whittle B. Constitutive nitric oxide modulates the injurious actions of vasopressin on rat intestinal microcirculation in acute endotoxaemia. Eur J Pharmacol 1994 260 : 265 268. (Pubitemid 24240033)
58. Lindner KH, Strohmenger HU, Ensinger H, et al. Stress hormone response during and after cardiopulmonary resuscitation. Anesthesiology 1992 77 : 662 668.
59. Lindner KH, Brinkmann A, Pfenninger EG, et al. Effect of vasopressin on hemodynamic variables, organ blood flow, and acid base status in pig model of cardiopulmonary resuscitation. Anesth Analg 1993 77 : 427 435. (Pubitemid 23263510)
60. Lindner KH, Prengel AW, Pfenninger EG, et al. Vasopressin improves vital organ blood flow during closed-chest cardiopulmonary resuscitation in pigs. Circulation 1995 91 : 215 221.
61. Wenzel V, Lindner KH, Prengel AW, et al. Endobronchial vasopressin improves survival during cardiopulmonary resuscitation in pigs. Anesthesiology 1997 86 : 1375 1381. (Pubitemid 27262316)
62. Wenzel V, Lindner KH, Augenstein S, et al. Intraosseous vasopressin improves coronary perfusion pressure rapidly during cardiopulmonary resuscitation in pigs. Crit Care Med 1999 27 (8) : 1565 1569. (Pubitemid 29406948)
63. Wenzel V, Lindner KH, Krismer AC, et al. Repeated administration of vasopressin but not epinephrine maintains coronary perfusion pressure after early and late administration during prolonged cardiopulmonary resuscitation in pigs. Circulation 1999 99 : 1379 1384. (Pubitemid 29129925)
64. Little CM, Marietta MH, Peng K, et al. Vasopressin alone or with epinephrine may be superior to epinephrine in a clinically relevant porcine model of pulseless electrical activity cardiac arrest. Am J Emerg Med 2006 24 : 810 814.
65. Prengel AW, Lindner KH, Keller A. Cerebral oxygenation during cardiopulmonary resuscitation with epinephrine and vasopressin in pigs. Stroke 1996 27 : 1241 1248. (Pubitemid 26226963)
66. Prengel AW, Linstedt U, Zenz M, et al. Effects of combined administration of vasopressin, epinephrine, and norepinephrine during cardiopulmonary resuscitation in pigs. Crit Care Med 2005 33 (11) : 2587 2591. (Pubitemid 41682112)
67. Wenzel V, Linder KH, Krismer AC, et al. Survival with full neurologic recovery and no cerebral pathology after prolonged cardiopulmonary resuscitation with vasopressin in pigs. J Am Coll Cardiol 2000 35 (2) : 527 533. (Pubitemid 30125548)
68. Popp E, Vogel P, Teschendorf P, et al. Vasopressors are essential during cardiopulmonary resuscitation in rats: is vasopressin superior to adrenaline? Resuscitation 2007 72 : 137 144.
69. Schmittinger CA, Astner S, Astner L, et al. Cardiopulmonary resuscitation with vasopressin in a dog. Vet Anaesth Analg 2005 32 : 112 114. (Pubitemid 41623677)
70. Lindner KH, Prengel AW, Brinkmann A, et al. Vasopressin administration in refractory cardiac arrest. Ann Intern Med 1996 124 : 1061 1064. (Pubitemid 126506754)
71. Morris DC, Dereczyk BE, Grzybowski M, et al. Vasopressin can increase perfusion pressure during human cardiopulmonary resuscitation. Acad Emerg Med 1997 4 : 878 883. (Pubitemid 27381660)
72. Lindner KH, Dirks B, Strohmenger HU. Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation. Lancet 1997 340 : 535 537. (Pubitemid 27092793)
73. Li PF, Chen TT, Zhand JM, et al. Clinical study on administration of vasopressin during closed-chest cardiopulmonary resuscitation. Chin Crit Care Med 1999 11 : 28 31.
74. Stiell IG, Hebert PC, Wells GA, et al. Vasopressin versus epinephrine for in-hospital cardiac arrest: a randomized controlled trial. Lancet 2001 358 : 101 109. (Pubitemid 32709848)
75. Jochberger S, Wenzel V, Dunser MW. Arginine vasopressin as a rescue vasopressor agent in operating room. Curr Opin Anaesthesiol 2005 18 : 396 404. (Pubitemid 41073136)
76. Wenzel V, Krismer AC, Arntz H, et al. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med 2004 350 (2) : 105 113. (Pubitemid 38056221)
77. Aung K, Htay T. Vasopressin for cardiac arrest. A systemic review and meta-analysis. Arch Intern Med 2005 165 : 17 24. (Pubitemid 40096077)
78. Callaway CW, Hostler D, Doshi AA, et al. Usefulness of vasopressin administered with epinephrine during out-of-hospital cardiac arrest. Cardiology 2006 98 : 1316 1321. (Pubitemid 44666635)
79. Grmec S, Mally S. Vasopressin improves outcome in out-of-hospital cardiopulmonary resuscitation of ventricular fibrillation and pulseless ventricular tachycardia: an observation cohort study. Cri Care 2006 10 (R13) : 1 7. (Pubitemid 47079808)
80. Stockman W, Keyser JD, Brabant S, et al. Colon ischaemia and necrosis as a complication of prolonged but successful CPR. Resuscitation 2006 71 : 260 262. (Pubitemid 44602314)
81. Kahn JM, Kress JP, Hall JB. Skin necrosis after extravasation of low-dose vasopressin administered for septic shock. Crit Care Med 2002 30 (8) : 1899 1901.
82. Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004 30 : 536 555. (Pubitemid 38541501)
83. ECC Committee. Subcommittees and Task Force of the American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2005 112 : IV1 IV203.
84. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001 345 : 1368 1377.
85. Powers J, Jacobi J. Pharmacologic treatment related to severe sepsis. AACN Adv Crit Care 2006 17 (4) : 423 432.
86. Aufderheide TP, Pirrallo RG, Yannopoulos D, et al. Incomplete chest wall decompression: a clinical evaluation of CPR performance by EMS personnel and assessment of alternative manual chest compression-decompression techniques. Resuscitation 2005 65 : 353 363. (Pubitemid 40298793)
87. Powell LL. Systemic inflammatory response in the cat: Current management recommendations. In: ACVIM Forum Proceedings; 2004: Minneapolis, MN. pp. 745-747.
88. Mathews KA. Indications and guidelines for "fluid" management in various situations. In: Proceedings of the Western Veterinary Conference; 2004: Las Vegas, NV. pp. 654-656.
89. Winso O, Biber B, Martner J. Does dopamine suppress stress-induced intestinal and renal vasoconstriction? Acta Anaesthesiol Scand 1985 29 (5) : 508 514. (Pubitemid 15047428)
90. Cadario BJ, Leathem AM. Drug Information Reference, 4th ed. Vancouver, BC : Drug and Poison Information Center 1996, pp. 1301 1303.
91. Plunkett SJ, McMicheal M. Cardiopulmonary resuscitation in small animal medicine: an update. J Vet Intern Med 2008 22 : 9 25.
92. Salam AM. The therapeutic potential of vasopressin in cardiopulmonary resuscitation. Expert Opin Pharmacother 2005 6 : 517 520. (Pubitemid 40521088)